Cypher Stent for Heart Disease

Manufactured by Johnson & Johnson, the Cypher Stent was approved by the Food and Drug Administration in 2003. The Cypher Stent is a tiny metal apparatus used in patients who have suffered a heart attack or have angina, a form of coronary artery disease which exhibits a build-up of plaque in the coronary arteries. The Cypher Stent is unique in that it releases an anti-rejection-type medication.

In 2006, about three years after FDA approval, the esteemed Cleveland Clinic (named one of the top 3 U.S. hospitals in 2006, by US News & World Report) released a very troubling analysis of drug-coated stents. The findings, the results of 14 thorough studies, showed that the drugs Sirolimus (Johnson & Johnson) and paclitaxel (Boston Scientific) seemed to be four to five times more likely to cause severe cardiac side effects.

Recent estimates speculate that there are more than 290 blood clots and 60 deaths linked to the Cypher Stent. These numbers are staggering and the risks are very serious. Among other side effects, Cypher Stent patients are at risk of:

• Heart attacts
• Pulmonary embolisms
• Strokes
• Blood clots
• Deep vein thrombosis

Additionally, patients with stents have reported a wide range of severe reactions to the drugs contained in stents. These reactions may include, but are not limited to:

• Rash
• Pain
• Fever
• Blood pressure irregularities
• Itching
• Hives

If you or someone you care about has a Cypher Stent and is exhibiting any of the symptoms listed above, please fill out our Case Review Contact Form to the right on this page to find out what your case is worth.

Defective Products
News Articles

2008 Tire Recalls
05/02/08 - (read more...)

Evenflo Recall of Discovery
Infant Child Restraints
02/04/08 - (read more...)

Medtronic Defibrillator Recall
12/03/07 - (read more...)

Trasylol Pulled from U.S. Market
11/05/07 - (read more...)

Tire Recalls
11/01/07 - (read more...)

Safety vs. Savings on Consumer Products
10/30/07 - (read more...)

Medtronic Defibrillator Recalled
10/30/07 - (read more...)

FDA Update On Trasylol
10/26/07 - (read more...)

Proposed Black Box Warning for Avandia
10/26/07 - (read more...)

Medtronic and FDA Face Scrutiny on Safety Issues
10/17/07 - (read more...)

Doctor Links a Man’s Illness to a Microwave Popcorn Habit
9/05/07 - (read more...)

Shorting Problem with Guidant ICD Device Causes Stir in EP Community
5/27/07 - (read more...)